Concepedia

Publication | Closed Access

Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory Mantle Cell Lymphoma: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study

25

Citations

0

References

2022

Year

No additional data available for this publication yet. Check back later!